Evidence map›Paper›PMID 21731065›Full record

ReviewNature structural & molecular biology2011

Unraveling the mechanism of BRCA2 in homologous recombination.

William K Holloman

Abstract readReview
In one paragraph

Review in Nature structural & molecular biology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 123 papers.

0numbers the graph read from it
0cells of the map it votes in
123citing papers in PubMed
9.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

123 citing papers in PubMed, 212 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Novel De NovoInternational journal of molecular sciences · 2025
    Article
  11. Role of BRCA1 in glioblastoma etiology.Cellular oncology (Dordrecht, Netherlands) · 2024
    Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

63 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

William K HollomanDepartment of Microbiology and Immunology, Weill Cornell Cancer Center, Weill Cornell Medical College, New York, New York, USA. wkhollo@med.cornell.edu
Cornell University · US

Funding

REC1 GENE CONTROLLING RECOMBINATION IN USTILAGOR01GM042482 · NIGMS · WEILL MEDICAL COLL OF CORNELL UNIV · PI HOLLOMAN, WILLIAM K. · 1989 to 2013
$4.3M
Mechanisms of Brh2-Promoted Recombinatinal RepairR01GM079859 · NIGMS · WEILL MEDICAL COLL OF CORNELL UNIV · PI HOLLOMAN, WILLIAM K. · 2007 to 2015
$2.8M
NIGMS NIH HHS GM042482NIGMS NIH HHS GM079859NIGMS NIH HHS R01 GM042482NIGMS NIH HHS R01 GM079859
6 · The paper itself

Abstract

BRCA2 is the product of a breast cancer susceptibility gene in humans and the founding member of an emerging family of proteins present throughout the eukaryotic domain that serve in homologous recombination. The function of BRCA2 in recombination is to control RAD51, a protein that catalyzes homologous pairing and DNA strand exchange. By physically interacting with both RAD51 and single-stranded DNA, BRCA2 mediates delivery of RAD51 preferentially to sites of single-stranded DNA (ssDNA) exposed as a result of DNA damage or replication problems. Through its action, BRCA2 helps restore and maintain integrity of the genome. This review highlights recent studies on BRCA2 and its orthologs that have begun to illuminate the molecular mechanisms by which these proteins control homologous recombination.

Indexed as

DNA RepairModels, GeneticRecombination, GeneticBinding SitesBRCA2 ProteinDNA DamageDNA, Single-StrandedProtein Structure, TertiaryRad51 RecombinaseBRCA2 ProteinDNA, Single-StrandedRad51 Recombinase

Identifiers

PMID21731065
PMCPMC3647347
OpenAlexW1970445060

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.